Why FingerPost?

A fingerpost is a signpost at a junction, that points in various different possible directions. For early-stage companies, the choices and uncertainty can be overwhelming. So, like a fingerpost, our experts identify the different possible paths. We help you by pulling on our experience and research, to create rational and robust assumptions that can guide you on which path to take.

FingerPost was set up in 2015 by Catherine Bacon. Her extensive experience in market access consulting, and from working with a variety of partners, helped her understand market access needs from a variety of perspectives. Cath recognised an unmet need for global market access support for small to medium biotech and pharmaceutical companies. Understanding that these companies often have gaps in market access expertise and limited budget and resources, she set about creating a new model. In founding FingerPost, she made it possible for companies to tap into effective and efficient support, even at the early stages of development.

In the past five years, we’ve completed more than 200 projects, helping clinical-stage biotech and pharmaceutical companies develop strong commercial strategies and plan for successful access to markets.